Tyler Robson



Tyler Robson Recent News

The Valens Company Signs Exclusive Cannabis Partnership With Coldhaus Distribution
The Valens Company Launches Exclusive Cannabis Brand In Quebec, Receives Notice From NASDAQ
The Valens Company Secures Agreement For Green Roads Kiosks In Major Malls Across The US
Valens Company Q1 Revenue Increases 26% Sequentially To $18.5M
The Valens Company Improves Recreational Cannabis Market Share In Canada
The Valens Company Posts 67% Higher Loss, Provides Strong 2023 Guidance With Revenue Of CA$225M
The Valens Co. Begins Producing Cannabis-Infused Beverages At GTA Facility, Signs Manufacturing Partnership
The Valens Company Launches Two New Cannabis Brands Across Value And Premium Markets
The Valens Company Teams Up With MTL Cannabis To Manufacture Pre-Rolls And Vapes
Valens Company Signs Agreements With Mexican Drug Supplier To Provide CBD Oil And Prebiotic Products
The Valens Company Borrows $31.3M To Retire Its Debt And Strengthen Balance Sheet
The Valens Company Shares Surge On $54.3M Citizen Stash Cannabis Acquisition
Canna Canes For Christmas: Aurora Partners With The Valens Co. To Produce Seasonal Offerings
The Valens Co. Reaches Third-Largest Cannabis Market In Canada
Valens Enters Into Six Cannabis Manufacturing Partnerships With Three Canadian LPs, Poised To Debut On NASDAQ
The Valens Company And Marijuana Retailer Fire & Flower Enter White Label Partnership
The Valens Company Gains Access to GMP Manufacturing in Australia, Expands International Outreach
The Valens Company Continues Buying Spree – Acquires Verse Cannabis On Heels Of Citizen Stash Acquisition
The Valens Company Buys Citizen Stash For $54.3M In All Stock Deal, To Create Company With $3.8B Addressable Market
The Valens Company Closes Its Largest Pre-Roll Manufacturing Agreement To Date
The Valens Company Moves Closer To Entering Quebec Cannabis Market – The Third Largest In Canada
Valens Company Teams Up With Harvest One To Produce And Distribute LivRelief's Cannabis-Infused Topicals
Cannabis Products Manufacturer, The Valens Company Posts 7% Higher Q2 Revenue Hitting $18.8M, Negative Adjusted EBITDA